Original Research
Accepted on 09 Jul 2025
Synergistic effects of combined hypnotic drugs on sleep in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596813
- 131 views
Type at least 3 characters
2,479 articles
Correction
Accepted on 09 Jul 2025
The antipsychotics functional index (AFI) in schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662228
Original Research
Accepted on 09 Jul 2025
α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626907
Opinion
Accepted on 08 Jul 2025
Frontiers in Pharmacology, Opinion
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1614460
- 107 views
Review
Accepted on 07 Jul 2025
Cerebral ischemia-reperfusion injury: mechanisms and promising therapies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613464
Original Research
Accepted on 07 Jul 2025
Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627465
- 119 views
Original Research
Published on 07 Jul 2025
Exploration of the potential neurotransmitter or neuromodulator-like properties of harmine: evidence from synthesis to synaptic modulation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588105
- 351 views
Original Research
Published on 07 Jul 2025
The kynurenine pathway as a potential link between ethanol-induced behavioral alterations and neuroinflammation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1628527
- 301 views
Original Research
Accepted on 04 Jul 2025
The effect of oral administration of NXP032 equivalent to intraperitoneal administration in an Alzheimer's disease model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1632640
Original Research
Published on 02 Jul 2025
Dexmedetomidine potently and reversibly regulates stress-mediated behaviors
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1589075
- 538 views
Hypothesis and Theory
Published on 02 Jul 2025
The antipsychotics functional index (AFI) in schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591763
- 761 views
Original Research
Published on 02 Jul 2025
Acute pharmacological effects of α-PVP in humans: a naturalistic observational study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626692
- 436 views
Review
Accepted on 01 Jul 2025
Genetic Implication of GABAB Receptors in the Etiology of Neurological and Psychiatric Disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1634128
- 217 views
Mini Review
Published on 01 Jul 2025
Clinical characterization and management of persons with comorbid epilepsy and depression: an expert opinion paper
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592650
- 317 views
Original Research
Published on 01 Jul 2025
Glutamatergic mechanisms in early salience processing
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1601797
- 266 views
Original Research
Accepted on 30 Jun 2025
Ursolic acid ameliorates cerebral ischemia-reperfusion injury by inhibiting NF-κB/NLRP3-mediated microglia pyroptosis and neuroinflammation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1622131
- 113 views